Variant report
Variant | nsv890040 |
---|---|
Chromosome Location | chr8:6031012-6065210 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs139292574 | chr8:6032463-6032464 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs372789501 | chr8:6032472-6032473 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs564153480 | chr8:6032499-6032500 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs533222020 | chr8:6032512-6032513 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs113934678 | chr8:6032525-6032526 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs150010681 | chr8:6032528-6032529 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs529530489 | chr8:6032529-6032530 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs184082925 | chr8:6032541-6032542 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs566411772 | chr8:6032547-6032548 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs535355321 | chr8:6032557-6032558 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs529833320 | chr8:6032561-6032562 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs114737236 | chr8:6032562-6032563 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs79529218 | chr8:6032582-6032583 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs539123065 | chr8:6032583-6032584 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs117623980 | chr8:6032593-6032594 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs149135532 | chr8:6032596-6032597 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs535669677 | chr8:6032607-6032608 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs546819214 | chr8:6032629-6032630 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs368974298 | chr8:6032640-6032641 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs112151225 | chr8:6032673-6032674 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs540946670 | chr8:6032684-6032685 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs557681595 | chr8:6032692-6032693 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs577976960 | chr8:6032711-6032712 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs12542866 | chr8:6032722-6032723 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs568301304 | chr8:6032728-6032729 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs4543562 | chr8:6032731-6032732 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs543172770 | chr8:6032736-6032737 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs192170550 | chr8:6032752-6032753 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs146460775 | chr8:6032753-6032754 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs375005986 | chr8:6032754-6032755 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs570456621 | chr8:6032755-6032756 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs4510891 | chr8:6032757-6032758 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
33 | rs549590353 | chr8:6032765-6032766 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs147844353 | chr8:6032788-6032789 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs535210714 | chr8:6032792-6032793 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs183840744 | chr8:6032798-6032799 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs552367481 | chr8:6037410-6037411 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs562676480 | chr8:6037413-6037414 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs186707214 | chr8:6037414-6037415 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs373494660 | chr8:6037415-6037416 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs548329340 | chr8:6037423-6037424 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs190461316 | chr8:6037425-6037426 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs534217734 | chr8:6037452-6037453 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs548117432 | chr8:6037468-6037469 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs181634480 | chr8:6037474-6037475 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs2570660 | chr8:6037491-6037492 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
47 | rs566795763 | chr8:6037503-6037504 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs151185353 | chr8:6037504-6037505 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs568948788 | chr8:6037512-6037513 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs140336948 | chr8:6037523-6037524 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Cancer | 20164920 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Prostate cancer | 17217626 | CNVD |
Developmental delay | 19128483 | CNVD |
Neuroticism | 17667963 | CNVD |
Leukoplakia | 24403051 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Breast cancer | 21364760 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Melanoma | 20688739 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:6032400-6032800 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
2 | chr8:6037400-6038600 | Enhancers | NHDF-Ad | bronchial |
3 | chr8:6037400-6039000 | Enhancers | Hela-S3 | cervix |
4 | chr8:6037800-6038200 | Enhancers | Primary neutrophils fromperipheralblood | blood |
5 | chr8:6037800-6038600 | Enhancers | Osteobl | bone |
6 | chr8:6037800-6038800 | Enhancers | NH-A | brain |
7 | chr8:6038400-6039000 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
8 | chr8:6041200-6042600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
9 | chr8:6041400-6042800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
10 | chr8:6054800-6055200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |